logo
[breadcrumb_custom]

Tag: Revance Therapeutics Inc. (NASDAQ:RVNC)

ALXO Stock
Finance

Revance Therapeutics Inc (RVNC) Stock: Navigating a Year of Stock Volatility

Examining a stock’s 52-week price history, encompassing its low and high prices, can reveal much about its existing condition and potential future trajectory. Revance Therapeutics Inc’s current trading price is -88.38% away from its 52-week high, while its distance from the 52-week low is 2.44%. The stock’s price range over this period has fluctuated between $4.31 and $37.98. The company, operating within the financial sector, had a trading volume of approximately 1.04 million for the day, which was noticeably lower than the average daily share volume of 1.77 million over the last 3 months. Revance Therapeutics Inc experienced a rather

AMZN
News

RVNC’s Financial Health: Exploring Revance Therapeutics Inc’s Debt-to-Equity Ratio of 1.79

Revance Therapeutics Inc’s stock market performance has been somewhat irregular. The 1-year high for the company’s stock was recorded at $37.98 on 05/09/23, with the lowest value being $5.00 on 02/01/24. 52-week price history of RVNC Stock Analyzing the 52-week price history of a stock, including its high and low prices, can provide valuable insight into its current status and potential future performance. Revance Therapeutics Inc’s current trading price is -85.70% away from its 52-week high, while its distance from the 52-week low is 8.60%. The stock’s price range for this period has remained between $5.00 and $37.98. The Healthcare